Table 1.
Sex | Pathology | Site | Age of spinal injury | Age of surgery | Years of drug treatment | |
---|---|---|---|---|---|---|
Ctrl 1 | Female | Cancer | – | – | 58 | – |
Ctrl 2 | Male | Cancer | – | – | 69 | – |
Ctrl 3 | Male | Cancer | – | – | 77 | – |
Ctrl 4 | Male | Cancer | – | – | 74 | – |
Ctrl 5 | Male | Cancer | – | – | 76 | – |
Ctrl 6 | Male | Cancer | – | – | 78 | – |
Pt 1 | Female | SCI | D8 | 31 | 44 | 13 |
Pt 2 | Female | SCI | D5 | 25 | 36 | 11 |
Pt 3 | Male | Myelite | D4 | 24 | 41 | 17 |
Pt 4 | Female | MS | S‐S** | 36 | 52 | 16 |
Pt 5 | Female | SCI | D8 | 29 | 45 | 16 |
Pt 6 | Male | SCI | D8 | 29 | 47 | 18 |
Pt 7 | Male | SCI | C6 | 28 | 35 | 7 |
Pt 8* | Male | SCI | D4 | 18 | 25 | 7 |
Ctrl: control; Pt: patient; SCL: spinal cord injury; MS: multiple sclerosis. *Non‐responder patient to botulinum toxin treatment. **Suprasacral.